3-O-[beta-D-xylopyranosyl(1->2)][-beta-D-xylopyranosyl(1->4)]-beta-D-glucopyranosiduronic acid 21-angeloyl-22-acetyl protoaescigenin

ID: ALA2018105

Chembl Id: CHEMBL2018105

PubChem CID: 70681243

Max Phase: Preclinical

Molecular Formula: C53H82O22

Molecular Weight: 1071.22

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: PaviosideH | PaviosideH|CHEMBL2018105

Canonical SMILES:  C/C=C(/C)C(=O)O[C@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C

Standard InChI:  InChI=1S/C53H82O22/c1-10-23(2)44(67)75-41-42(70-24(3)56)53(22-55)26(17-48(41,4)5)25-11-12-30-49(6)15-14-32(50(7,21-54)29(49)13-16-51(30,8)52(25,9)18-31(53)59)71-47-39(73-46-36(63)34(61)28(58)20-69-46)37(64)38(40(74-47)43(65)66)72-45-35(62)33(60)27(57)19-68-45/h10-11,26-42,45-47,54-55,57-64H,12-22H2,1-9H3,(H,65,66)/b23-10-/t26-,27+,28+,29+,30+,31+,32-,33-,34-,35+,36+,37-,38-,39+,40-,41-,42-,45-,46-,47+,49-,50+,51+,52+,53-/m0/s1

Standard InChI Key:  UBABTSJIVMIEKX-VGGJEQQDSA-N

Alternative Forms

  1. Parent:

    ALA2018105

    PAVIOSIDEH

Associated Targets(non-human)

J774 (3120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WEHI-164 (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1071.22Molecular Weight (Monoisotopic): 1070.5298AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Lanzotti V, Termolino P, Dolci M, Curir P..  (2012)  Paviosides A-H, eight new oleane type saponins from Aesculus pavia with cytotoxic activity.,  20  (10): [PMID:22507208] [10.1016/j.bmc.2012.03.048]

Source